C07D 333/20
By nitrogen atoms
Official title: by nitrogen atoms (nitro, nitroso radicals C07D333/12)
C07D333/20 (By nitrogen atoms) appears on 1,236 US grants and 1,039 published applications in this corpus.
Search patents in C07D- Granted patents
- 1,236
- Published applications
- 1,039
- Assignees
- 679
- Inventors
- 4,094
- Latest grant
- 8 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 8 | 0 |
| 1977 | 4 | 0 |
| 1978 | 24 | 0 |
| 1979 | 5 | 0 |
| 1980 | 17 | 0 |
| 1981 | 21 | 0 |
| 1982 | 15 | 0 |
| 1983 | 8 | 0 |
| 1984 | 17 | 0 |
| 1985 | 15 | 0 |
| 1986 | 9 | 0 |
| 1987 | 15 | 0 |
| 1988 | 16 | 0 |
| 1989 | 18 | 0 |
| 1990 | 22 | 0 |
| 1991 | 24 | 0 |
| 1992 | 21 | 0 |
| 1993 | 26 | 0 |
| 1994 | 22 | 0 |
| 1995 | 18 | 0 |
| 1996 | 28 | 0 |
| 1997 | 23 | 0 |
| 1998 | 22 | 0 |
| 1999 | 11 | 0 |
| 2000 | 26 | 0 |
| 2001 | 30 | 4 |
| 2002 | 55 | 48 |
| 2003 | 46 | 75 |
| 2004 | 44 | 63 |
| 2005 | 25 | 60 |
| 2006 | 39 | 75 |
| 2007 | 41 | 69 |
| 2008 | 38 | 63 |
| 2009 | 44 | 64 |
| 2010 | 50 | 50 |
| 2011 | 52 | 45 |
| 2012 | 38 | 44 |
| 2013 | 38 | 44 |
| 2014 | 42 | 41 |
| 2015 | 31 | 37 |
| 2016 | 28 | 36 |
| 2017 | 32 | 36 |
| 2018 | 24 | 27 |
| 2019 | 22 | 21 |
| 2020 | 21 | 27 |
| 2021 | 13 | 29 |
| 2022 | 17 | 23 |
| 2023 | 7 | 11 |
| 2024 | 12 | 19 |
| 2025 | 7 | 16 |
| 2026 | 5 | 12 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Compounds for the treatment of bacterial infections and potentiation of antibiotics8 Sep 2026US 12,728,105 B2Georgia State University Research Foundation, Inc.
- Vesicular monoamine transporter-2 ligands and their use in the treatment of psychostimulant abuse26 May 2026US 12,637,410 B2University of Kentucky Research Foundation
- Sulfur and amide tropolone inhibitors of nucleotidyl transferases and uses therefor21 Apr 2026US 12,606,529 B2Research Foundation of the City University of New York
- 3-aryloxy-3-five-membered heteroaryl propylamine compound, and crystal form and use thereof10 Mar 2026US 12,570,643 B2Shanghai Leado Pharmatech Co. Ltd.
- Heterocyclyl pyrimidines and triazines as novel fungicides3 Mar 2026US 12,565,489 B2Bayer Aktiengesellschaft
- Novel carboxamide derivatives8 Oct 2026US 2026/0308149 A1Angelini Pharma S.P.A.
- Pyridine-piperazine-based scaffolds as highly potent and selective neurolysin activators1 Oct 2026US 2026/0294897 A1Board of Regents of the University of Nebraska
- Hdac1/2 selective inhibitor and use thereof1 Oct 2026US 2026/0297110 A1Wigen Biomedicine Technology (Shanghai) Co., Ltd.
- Rotigotine prodrug derivatives, pharmaceutical compositions thereof and uses thereof10 Sep 2026US 2026/0263416 A1Yantai Institute of Pharmaceutical Science
- Regio-controllable [2+2] benzannulation with two adjacent c(sp3)-h bonds20 Aug 2026US 2026/0242341 A1The Scripps Research Institute
Most cited
By later US patents
- Heterocyclic containing biphenyl aP2 inhibitors and method135US 6,548,529 B1Bristol-Myers Squibb Company · 2003
- Urea derivatives and their use as ACAT inhibitors134US 5,621,010 ANisshin Flour Milling Co., Ltd. · 1997
- Conformationally restricted aromatic inhibitors of microsomal triglyceride transfer protein and method125US 5,760,246 A1998
- Catecholamine surrogates useful as .beta..sub.3 agonists122US 5,776,983 ABristol-Myers Squibb Company · 1998
- 3-aryloxy-3-substituted propanamines89US 5,023,269 AEli Lilly and Company · 1991